NYSE · SYYConsumer DiscretionaryWholesale Trade

Sysco financials

$78.57+0.14%
Close Sep 28, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ4 '26
Jun 27
Q3 '26
Mar 28
Q2 '26
Dec 27
Q1 '26
Sep 27
Q4 '25
Jun 28
Q3 '25
Mar 29
Q2 '25
Dec 28
Q1 '25
Sep 28
Q4 '24
Jun 29
Q3 '24
Mar 30
Q2 '24
Dec 30
Q1 '24
Sep 30
Revenue$22.12B$20.52B$20.76B$21.15B$21.14B$19.60B$20.15B$20.48B$20.56B$19.38B$19.29B$19.62B
Gross profit$4.13B$3.81B$3.79B$3.90B$3.99B$3.58B$3.65B$3.75B$3.84B$3.61B$3.51B$3.65B
Gross margin18.7%18.6%18.3%18.4%18.9%18.3%18.1%18.3%18.7%18.6%18.2%18.6%
Operating income$983.0M$619.0M$692.0M$800.0M$888.0M$681.0M$712.0M$808.0M$976.0M$722.0M$700.0M$804.0M
Net income$551.0M$340.0M$389.0M$476.0M$531.0M$401.0M$406.0M$490.0M$612.0M$425.0M$415.0M$503.0M
Net margin2.5%1.7%1.9%2.3%2.5%2.0%2.0%2.4%3.0%2.2%2.2%2.6%
Diluted EPS$1.15$0.71$0.81$0.99$1.10$0.82$0.82$0.99$1.23$0.85$0.82$0.99
EBITDA$1.24B$870.0M$932.0M$1.03B$1.12B$917.0M$950.0M$1.04B$976.0M$944.0M$919.0M$1.01B
Operating cash flow$1.18B$852.0M$525.0M$86.0M$1.19B$819.0M$445.0M$53.0M$1.62B$517.0M$769.0M$87.0M
Free cash flow$936.0M$691.0M$385.0M-$74.0M$819.0M$620.0M$234.0M-$69.0M$1.31B$334.0M$593.0M-$84.0M
Diluted shares480.2M481.2M480.7M480.4M483.4M489.3M492.8M493.8M497.5M501.9M505.9M507.1M

Balance sheet

Period endJun 27Mar 28Dec 27Sep 27Jun 28Mar 29
Cash & equivalents$1.79B$1.90B$1.22B$844.0M$1.07B$1.53B
Short-term investments$0.00$0.00$0.00$0.00$0.00$0.00
Total debt$13.52B$14.01B$13.59B$13.35B$13.31B$13.47B
Total assets$28.40B$27.98B$27.18B$27.04B$26.77B$26.35B
Total liabilities$25.73B$25.69B$24.84B$24.93B$24.92B$24.40B
Shareholders' equity$2.67B$2.30B$2.28B$2.07B$1.83B$1.92B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology